Abstract
ObjectivesThe BEST3 trial demonstrated the efficacy and safety of the Cytosponge-trefoil factor 3, a cell collection device coupled with the biomarker trefoil factor 3, as a tool for detecting Barrett’s...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have